[Etiology and drug resistance of non-typhi Salmonella in Henan province, 2011-2015]. 2016

J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
Pathogenic Microbiology Laboratory of Institute for Infectious Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.

Objective: To analyze the serotypes and antibiotic resistance phenotypes of non-typhi Salmonella strains in Henan province from 2011 to 2015. Methods: The stool samples were collected from diarrhea patients, and enriched with SBG enrichment broth and the pathogen isolation was conducted with CHROMAgar selective culture medium at 37 ℃ for 18-24 hours using KIA/MIU biochemical action and API20E biochemical system slab to identify Salmonella strains. The serotypes of all the positive strains were detected with SSI Salmonella typing sera. According to K-B drug susceptibility testing method published by USA clinical and Laboratory Standards Institute (CLSI), the antibiotics resistant phenotype of the positive strains were analyzed. Results: A total of 1 351 strains of non-typhi Salmonella were isolated, in which 811 were from males, 540 were from females. The ratio of men to women was 1.5∶1. Children and young adults were mainly affected. The pathogen isolation was mainly in May-October during a year. The 1 351 strains of non-typhi Salmonlla were divided into 58 serotypes. S. enteritidis, S. typhimurium, S. agona, S. derby, S. indiana, S. senftenberg and S. thompson ranked 1st-7th. The drug-resistance rate of the 1 351 strains was 46.1% to synthetic broad-spectrum penicillin ampicillin (AMP), 19.5% and 21.2% to the three generation cephalosporin ceftazidime (CAZ) and cefotaxime (CTX), 8.8% to the four generation cephalosporins cefepime (FEP), 58.7% to the one generation of quinolones nalidixic acid (NAL), 14.7% to the three generation fluoroquinolone ciprofloxacin (CIP) and norfloxacin (NOR), 25.0% and 35.6% to aminoglycoside antibiotic gentamicin (GEN) and streptomycin (STR), 35.4% to amphenicols (CHL), 31.7% to sulfonamide trimethoprim (TMP) and 37.8% to tetracycline (TET). Totally 879 strains were multidrug resistant (65.1%): 350 strains were resistant to 3-4 kinds of antibiotics (25.9%), 309 strains were resistant to 5-7 kinds of antibiotics (22.9%), 174 strains were resistant to 8-10 kinds of antibiotics (12.9%) and 48 strains were resistant to 11-12 kinds of antibiotics (3.6%). Conclusion: The serotypes of non-typhi Salmonella strains isolated from Henan province varied, some strains were resistant to 12 kinds of antibiotics commonly used in clinical treatment and the multidrug resistance has become serious.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
November 2017, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
December 2016, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
October 1996, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
October 2012, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
September 2012, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
June 2016, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
March 1992, Medicina clinica,
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
November 2012, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
October 1992, Lancet (London, England),
J Y Zhao, and Y J Mu, and B F Zhang, and S L Xia, and J Su, and X Y Huang, and B L Xu
February 1977, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!